Guided Therapeutics (GTHP) Retained Earnings (2016 - 2025)
Guided Therapeutics' Retained Earnings history spans 16 years, with the latest figure at -$157.1 million for Q4 2025.
- On a quarterly basis, Retained Earnings fell 2.18% to -$157.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$157.1 million, a 2.18% decrease, with the full-year FY2025 number at -$157.1 million, down 2.18% from a year prior.
- Retained Earnings hit -$157.1 million in Q4 2025 for Guided Therapeutics, down from -$155.8 million in the prior quarter.
- Over the last five years, Retained Earnings for GTHP hit a ceiling of -$140.6 million in Q1 2021 and a floor of -$157.1 million in Q4 2025.
- Historically, Retained Earnings has averaged -$149.0 million across 5 years, with a median of -$150.3 million in 2023.
- Biggest five-year swings in Retained Earnings: plummeted 1046546.38% in 2021 and later decreased 1.57% in 2024.
- Tracing GTHP's Retained Earnings over 5 years: stood at -$142.4 million in 2021, then decreased by 3.49% to -$147.4 million in 2022, then dropped by 2.55% to -$151.1 million in 2023, then fell by 1.71% to -$153.7 million in 2024, then fell by 2.18% to -$157.1 million in 2025.
- Business Quant data shows Retained Earnings for GTHP at -$157.1 million in Q4 2025, -$155.8 million in Q3 2025, and -$155.0 million in Q2 2025.